eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
2/2008
vol. 3
 
Share:
Share:
more
 
 
abstract:

Nonalcoholic steatohepatitis

Wojciech Deroń
,
Katarzyna Krawczyk
,
Ewa Małecka-Panas

Przegląd Gastroenterologiczny 2008; 3 (2): 118–124
Online publish date: 2008/04/18
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Nonalcoholic steatohepatitis (NASH) is a disease that is strictly related to nonalcoholic fatty liver disease. In the biopsy we could find both fatty hepatocyte factors and their inflammation features. Frequent occurrence of sickness is correlated with overweight, obesity, diabetes as well as hyperlipidaemia. The only way to get a certain diagnosis is to make a biopsy. In the study there are presented results of research on drugs that may help hinder progression, stop or reduce fatty liver features.
keywords:

nonalcoholic steatohepatitis, NASH, liver biopsy

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe